Silver Book Fact

Between 1998 and 2008, the rate of death attributable to cardiovascular disease declined 30.6%.

Roger, Veronique L., Alan S. Go, Donald M. Lloyd-Jones, Emelia J. Benjamin, Jarret D. Berry, et al.; on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics–2012 Update. Circulation. 2012; 125: e2-e220. http://circ.ahajournals.org/content/125/1/e2

Reference

Title
Heart Disease and Stroke Statistics–2012 Update
Publication
Circulation
Publisher
American Heart Association
Publication Date
2012
Authors
Roger, Veronique L., Alan S. Go, Donald M. Lloyd-Jones, Emelia J. Benjamin, Jarret D. Berry, et al.; on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Pages
e2-e220
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Aspirin, beta-blockers, angiotensin-converting enzyme inhibitors, and statins, when taken in combination, have been estimated to reduce the relative risk of coronary heart disease mortality by 80%, compared with a placebo.  
  • Satisfaction with HVD Treatment
    Among treated heart valve disease (HVD), 96% express “full satisfaction” and 78% are “very satisfied” with their treatment.  
  • A major objective is to control blood pressure and preempt primary and secondary stroke. Assessing specific antihypertensive therapies will identify specific treatments that will lower blood pressure.  
  • A recent data analysis of more than 2,700 stroke patients from the U.S. and Europe confirmed tPA’s effectiveness, which could save the U.S. nearly $50 million a year.  
  • There are currently 312 medicines in development for heart disease and stroke.